-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.
-
Summary
-
Harvard Bioscience Inc quarterly Deferred Income Tax Assets, Net history and growth rate from Q4 2018 to Q4 2023.
- Harvard Bioscience Inc Deferred Income Tax Assets, Net for the quarter ending December 31, 2023 was $436K, a 30.9% increase year-over-year.
Deferred Income Tax Assets, Net, Quarterly (USD)
Deferred Income Tax Assets, Net, YoY Quarterly Growth (%)